Drug Search Results
More Filters [+]

Bencycloquidium

Alternative Names: bencycloquidium
Latest Update: 2024-03-04
Latest Update Note: Clinical Trial Update

Product Description

Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis (Sourced from: https://pubmed.ncbi.nlm.nih.gov/32623510/)

Mechanisms of Action: M1 Antagonist,M3 Antagonist Binder

Novel Mechanism: Yes

Modality: N/A

Route of Administration: Nasal,Inhalant

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Yingu Pharmaceutical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Bencycloquidium

Countries in Clinic: China

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Sneezing

Phase 1: Chronic Obstructive Pulmonary Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20211344

P3

Recruiting

Sneezing

None

CTR20212431

P1

Not yet recruiting

Chronic Obstructive Pulmonary Disease

None

Recent News Events